| Literature DB >> 31137984 |
Zahra Gholamnezhad1,2, Mohammad Hossein Boskabady1,2, Mahmoud Hosseini3.
Abstract
Nigella sativa (N. sativa) was shown to recover fatigue and imbalanced immune system. Therefore, effect of chronic administration of N. sativa hydroethanolic extract on splenocytes response in sedentary and exercised animals, was evaluated. Male Wistar rats were randomly divided into non-treated (control sedentary (C), moderately trained (MT; Velocity 20 m/min, 30 min/day 8 weeks), and over-trained (OT; Velocity 25 m/min, 60 min/day 11 weeks)), and N. sativa-treated animals (Nisa, 200 mg/kg, orally) (control (Nisa-C), moderately trained (Nisa-MT) and over-trained (Nisa-OT)). Finally, cell viability and proliferation, as well as interleukin 4 (IL-4) and interferon-γ (IFN-γ) secretion in non-stimulated and concanavalin A (Con A)-stimulated splenocytes, were evaluated. In the absence of the mitogen, cell viability in Nisa-C and Nisa-OT, cell proliferation in Nisa-C and Nisa-MT, IFN-γ concentration in Nisa-MT and Nisa-OT and IFN-γ/IL-4 ratio in Nisa C, Nisa-MT and Nisa-OT were higher compared to non-treated groups; but, IL-4 level in Nisa-MT was lower than non-treated groups. In the presence of the mitogen, cell viability in Nisa-C and Nisa-OT, IL-4 concentration in Nisa-C and Nisa-OT groups, and IFN-γ concentration and IFN-γ/IL-4 ratio in Nisa-MT were higher, while IFN-γ/IL-4 ratio was lower in Nisa-C group compared to non-treated groups. Moreover, IFN-γ/IL-4 ratio in stimulated and non-stimulated splenocytes supernatant was higher in Nisa-MT compared to Nisa-C and Nisa-OT groups. N. sativa chronic administration may shift Th1/Th2 cytokines profile of splenocytes towards Th1, especially in over-trained and non-stimulated condition. Moderate exercise and N. sativa supplementation may improve disorders associated with elevated Th2 such as overtraining syndrome.Entities:
Keywords: Nigella sativa; Th1/Th2; moderate exercise; overtraining; rat; splenocyte
Mesh:
Substances:
Year: 2019 PMID: 31137984 DOI: 10.1080/01480545.2019.1617301
Source DB: PubMed Journal: Drug Chem Toxicol ISSN: 0148-0545 Impact factor: 3.356